During the past decade, UM Saint Joseph Medical Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 16 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 10 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UM Saint Joseph Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "Abbott Medical Devices" with 5 trials sponsored, "University of Maryland, Baltimore" with 4 trials sponsored and "Aeris Therapeutics" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UM Saint Joseph Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "UM Saint Joseph Medical Center" are "Coronary Artery Disease" (7 trials), "Breast Cancer" (3 trials), "Invasive Breast Carcinoma" (3 trials), "Myocardial Ischemia" (3 trials) and "Coronary Artery Stenosis" (2 trials). Many other conditions were trialed in "UM Saint Joseph Medical Center" in a lesser frequency.

Most popular intervention types in "UM Saint Joseph Medical Center" are "Drug" (33 trials), "Other" (22 trials), "Device" (11 trials), "Biological" (10 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (11 trials), "Laboratory Biomarker Analysis" (10 trials), "Placebo" (8 trials), "Questionnaire Administration" (7 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "UM Saint Joseph Medical Center" are 49 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "UM Saint Joseph Medical Center". undefined are not yet recruiting, 5 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in UM Saint Joseph Medical Center, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in UM Saint Joseph Medical Center, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".

UM Saint Joseph Medical Center has several departments that took part in Clinical trials: "Cancer Institute at St. Joseph Medical Center" - 8 trials